Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment.
Kozuka R, Enomoto M, Dong MP, Hai H, Thuy LTT, Odagiri N, Yoshida K, Kotani K, Motoyama H, Kawamura E, Hagihara A, Fujii H, Uchida-Kobayashi S, Tamori A, Kawada N.
Kozuka R, et al. Among authors: fujii h.
Sci Rep. 2022 Jan 7;12(1):105. doi: 10.1038/s41598-021-03706-w.
Sci Rep. 2022.
PMID: 34996935
Free PMC article.